Question

Difficulty: Very hardPharmacologic Interventions

Paramedics rush a cyanotic, gasping male patient into the resuscitation bay after he collapsed in a local park. Bystanders reported the patient was swarmed by yellow jackets approximately 15 minutes prior. The patient's spouse, who arrives shortly after, provides a medication list indicating he takes carvedilol, sacubitril-valsartan, empagliflozin, and apixaban for a history of heart failure with reduced ejection fraction. Vital signs on the monitor display a blood pressure of 68/36 mmHg, a pulse of 115/min, and an oxygen saturation of 85% on room air. Examination shows profound periorbital and labial edema, audible stridor, widespread urticaria, and poor air entry bilaterally with faint wheezing. Establish the most appropriate chronological sequence of pharmacologic interventions to stabilize this patient.

  1. 1Administer 0.3 mg to 0.5 mg of intramuscular epinephrine
  2. 2Infuse 1 to 2 liters of rapid intravenous 0.9% sodium chloride
  3. 3Administer 1 to 5 mg of intravenous glucagon
  4. 4Administer 125 mg of intravenous methylprednisolone

Answer

The correct sequence is to first administer intramuscular epinephrine, followed by a rapid intravenous crystalloid bolus, then intravenous glucagon, and finally intravenous methylprednisolone.
The patient presents with severe anaphylactic shock (hypotension, airway edema, wheezing, urticaria) and is concurrently taking a beta-blocker (carvedilol). The correct sequential priority begins with intramuscular epinephrine. Despite the patient's beta-blocker use, epinephrine remains the unequivocal first-line treatment to halt mast cell degranulation. Because anaphylaxis results in massive capillary leak and distributive shock, rapid intravenous crystalloid administration is the immediate next step to restore preload. Patients on beta-blockers often have refractory shock despite epinephrine and fluids due to beta-receptor antagonism. In these instances, intravenous glucagon is the specific rescue agent; it activates adenylate cyclase independently of the beta-receptor, thereby increasing intracellular cAMP to provide inotropy, chronotropy, and bronchodilation. Finally, after the patient is acutely stabilized hemodynamically and respiratory-wise, intravenous methylprednisolone is administered. Corticosteroids provide no acute relief due to their delayed onset but are essential for preventing a biphasic reaction.

Step-by-Step Solution

1
Administer intramuscular epinephrine into the anterolateral thigh.
Stimulates alpha-1 and beta-2 receptors (though beta-2 may be partially blunted by carvedilol).
It is the absolute first-line, life-saving intervention for anaphylaxis to treat upper airway obstruction and prevent cardiovascular collapse.
2
Infuse a rapid bolus of 0.9% sodium chloride.
Increases intravascular volume and cardiac preload.
Anaphylaxis is a form of distributive shock involving up to 35% loss of intravascular volume into tissues within 10 minutes, requiring aggressive fluid resuscitation.
3
Administer intravenous glucagon.
Increases intracellular cAMP levels independently of the beta-adrenergic receptor.
Patients on beta-blockers frequently exhibit refractory hypotension and bronchospasm during anaphylaxis. Glucagon provides necessary inotropy, chronotropy, and bronchodilation bypassing the blockade.
4
Administer intravenous methylprednisolone.
Alters gene transcription to downregulate the inflammatory response over several hours.
Corticosteroids are adjunctive therapies given after acute stabilization to prevent protracted or biphasic anaphylactic reactions.

Key Concept

In patients experiencing anaphylactic shock while on beta-blocker therapy, intramuscular epinephrine remains the first-line intervention, followed closely by aggressive fluid resuscitation. Intravenous glucagon is uniquely indicated as an acute rescue agent for refractory symptoms, while corticosteroids are strictly adjunctive therapies for preventing delayed reactions.
Estimated Time:2m 0s
Rate this question